The present retrospective study demonstrated a favorable prognostic impact of tumor-infiltrating plasma cells within the described collective of 107 triple-negative breast cancer patients, which were analyzed immunohistochemically with regard to the expression of the plasma cell markers CD38 and IgκC. The gene discussed is CD38; the disease is triple-negative breast carcinoma.